Protagen closes new Round of Financing for the Development of molecular Diagnostics for Prostate Cancer and Multiple Sclerosis Dortmund, Germany and New Jersey, USA, August 3, 2009: Protagen AG, an international leading provider of GMP compliant protein analytical services, protein bioinformatics, and protein arrays announces the closing of a new € 3.7 million financing round. […]
Celebrates Technical Achievements Researchers redefining what’s possible in medical diagnostics and life sciences – Team helps GE to expand Healthcare business NISKAYUNA, N.Y.–From creating a new business in digital pathology to developing next generation diagnostic imaging agents and life sciences tools that are breaking new ground in the detection and treatment of disease, the Biosciences […]
Software Monitors and Reports Emerging Infection Issues SPARKS, Md., Aug. 6 — BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX – News), announced today the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among […]
The NIAID-Supported Pathogen Functional Genomics Resource Center at the J. Craig Venter Institute Offers New Affymetrix Array for Faster Identification of E. Coli and Shigella – Custom Microarray Allows Scientists to Identify Different Strains of the Potentially Fatal Foodborne Pathogens SANTA CLARA, Calif. & ROCKVILLE, Md.–Affymetrix, Inc. (Nasdaq:AFFX) and the National Institute of Allergy and […]
Monsanto and TwistDx Begin Field Trials of Rapid Diagnostic Tests for More Efficient Delivery of Biotech Crops CAMBRIDGE, England–TwistDx, a developer of point-of-use nucleic acid diagnostics, announced today that they have made strong progress toward developing rapid, DNA-based field tests with Monsanto Company (NYSE:MON). Monsanto plans to use the tests to enhance the efficiency with […]
MANCHESTER, England–DxS Ltd, a personalised medicine company and leaders in the provision of companion diagnostics, has announced it is working closely with AstraZeneca to make available a companion diagnostic for use with IRESSA™ (gefitinib), AstraZeneca’s treatment for non small cell lung cancer (NSCLC). DxS’ clinical diagnostic, the TheraScreen®: EGFR29 Mutation Kit will be used to […]
SAN DIEGO–Cytori Therapeutics (NASDAQ:CYTX) was informed by the U.S. Food and Drug Administration (FDA) that the Celution® 700 System will be regulated as a medical device under the Federal Food, Drug, and Cosmetic Act. This determination, in response to Cytori’s Request for Designation, clears the way for Cytori to compile and submit a marketing application […]
Source BioScience plc (LSE: SBS), the provider of expert, quality services to the healthcare, pharma biotech and life science research sector, is pleased to announce an extension to the existing agreement to supply cytology services and automated imaging technology to Cervical Screening Wales (“CSW”). HIGHLIGHTS * Contract to supply liquid based cytology equipment and reagents […]
Idaho Technology Receives $3.6M Grant to Further Develop Diagnostic Medical Testing Platform for Underserved Populations SALT LAKE CITY–Idaho Technology, Inc. has been awarded $3.6 million from the National Institutes of Health to further develop the Point-of-Care FilmArray™ (POC FilmArray), a clinical diagnostic testing platform designed for underserved populations including the urban poor and rural communities. […]
BioTrove Installs First European RapidFire® System at Boehringer Ingelheim and Obtains CE Mark for the Instrument Novel RapidFire CE Marked System Successfully Evaluated for In Vitro ADME Studies, Enhances Productivity WOBURN, Mass.–BioTrove, Inc. today announced its innovative RapidFire® High-Throughput Mass Spectrometry (RF-MS) screening platform was installed in its first European customer site at Boehringer Ingelheim […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
